Evidence map›Paper›PMID 39528903›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Immunohistochemical-Based Molecular Subtypes of Female Breast Cancer: A Retrospective Cross-Sectional Study at Cheikh Khalifa Hospital in Casablanca, Morocco.

Bouaddi Oumnia, Diaby Maladho, Gordon Amanda, Kaikani Wafaa, Guessous Fadila, Chahboune Mohamed, Adil Najdi, Al Bouzidi Abderrahmane, Nejjari Chakib, Ismaili Nabil and 1 more

Abstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bouaddi OumniaMohammed VI International School of Public Health, Mohammed VI University of Sciences and Health, Casablanca, Morocco.ORCID 0000-0001-9114-6889
Diaby MaladhoMohammed VI International School of Public Health, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
Gordon AmandaUniversity of Minnesota School of Public Health, Minneapolis, MN, USA.
Kaikani WafaaDepartment of Oncology, Faculty of Medicine, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
Guessous FadilaFaculty of Medicine, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
Chahboune MohamedLaboratory of Sciences and Health Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat, Morocco.
Adil NajdiDepartment of Epidemiology, Faculty of Medicine and Pharmacy, Tangier, Morocco.
Al Bouzidi AbderrahmaneLaboratory of Pathological Anatomy, Cheikh Khalifa International University Hospital, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
Nejjari ChakibFaculty of Medicine, Euromed Research Center, Euromed University of Fez (UEMF), Fez, Morocco.
Ismaili NabilDepartment of Oncology, Faculty of Medicine, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
Khalis MohamedMohammed VI International School of Public Health, Mohammed VI University of Sciences and Health, Casablanca, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBreast cancer is a major public health concern worldwide and the most prevalent form of cancer in Morocco. This study aimed to describe the histological and immunohistochemical profiles of breast cancer in women admitted to Cheikh Khalifa Hospital in Casablanca, Morocco.

methodsThis is a retrospective cross-sectional study. All histologically confirmed female breast cancer cases diagnosed between January 2017 and May 2021 at the Cheikh Khalifa University Hospital were included in the study. Data were collected from patient electronic medical records. Using an electronic sheet, information was collected about the socio-demographic characteristics of the patients, clinical features, histopathology, molecular characteristics, treatment received, and progression.

resultsInvasive carcinoma of no special type was the most common type of cancer accounting for 90.7% of all cases. The majority of the tumors (56.1%) were grade II tumors. About 42.1% of tumors were lymph node-positive and only 13.4% developed distant metastasis. Immunohistochemical data revealed that 57.9% of the tumors in this study were hormone receptor-positive (ER+ and PR+), 74.4% were estrogen receptor-positive (ER+), 58.5% were progesterone receptor positive (PR+), and 18.9% were HER2 positive (HER2+). The most common molecular subtype was Luminal A-like (43.9%). A statistically significant difference was found in histological grades across the four molecular subtypes (

conclusionsOur findings should be used to guide breast cancer management policies in Morocco. Larger cohort studies are needed to determine the specificity of the breast cancer profile in Morocco as well as the epidemiological risk factors specific to every subtype.

Indexed as

Breast NeoplasmsImmunohistochemistryAdultAgedBiomarkers, TumorCross-Sectional StudiesErb-b2 Receptor Tyrosine KinasesFemaleHumansMiddle AgedMoroccoReceptors, EstrogenReceptors, ProgesteroneRetrospective StudiesBiomarkers, TumorERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, Progesteronebreast cancercancer epidemiologyimmunohistochemistrymolecular subtypesMorocco

Identifiers

PMID39528903
PMCPMC11555740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.